Response to comment by P. Vassilakopoulos and colleagues

Haematologica. 2015 Nov;100(11):e482. doi: 10.3324/haematol.2015.134288.
No abstract available

Keywords: aggressive B-cell lymphoma; first remission; randomized trial; rituximab maintenance.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols*
  • Female
  • Humans
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male
  • Rituximab / therapeutic use*

Substances

  • Rituximab